Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 4,428,072 | 4,747,373 | +319,301 | $104.41M | $130.55M | 11.41% | +$26.14M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,845,000 | 2,167,793 | +322,793 | $63.03M | $99.85M | 8.72% | +$36.82M |
| Nuvalent Inc | 828,778 | 1,331,037 | +502,259 | $38.10M | $97.95M | 8.56% | +$59.85M |
| Vera Therapeutics, Inc.CL A(VERA) | 5,450,000 | 5,450,000 | 0 | $74.72M | $83.82M | 7.32% | +$9.10M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,075,000 | 1,550,000 | -525,000 | $47.57M | $71.25M | 6.23% | +$23.68M |
| Vaxcyte, Inc.(PCVX) | 1,100,000 | 1,100,000 | 0 | $56.08M | $69.08M | 6.04% | +$13.00M |
| Cabaletta Bio, Inc.(CABA) | 2,525,753 | 1,900,000 | -625,753 | $38.44M | $43.13M | 3.77% | +$4.69M |
| Immunovant, Inc.(IMVT) | 1,000,000 | 1,000,000 | 0 | $38.39M | $42.13M | 3.68% | +$3.74M |
| Viridian Therapeutics, Inc.(VRDN) | 2,200,000 | 1,924,074 | -275,926 | $33.75M | $41.91M | 3.66% | +$8.16M |
| Arvinas, Inc.(ARVN) | 0 | 1,000,000 | +1,000,000 | $0 | $41.16M | 3.60% | +$41.16M |
| Spyre Therapeutics, Inc.(SYRE) | 116,324 | 1,884,084 | +1,767,760 | $1.42M | $40.55M | 3.54% | +$39.12M |
| Enliven Therapeutics Inc | 2,901,816 | 2,901,816 | 0 | $39.64M | $40.16M | 3.51% | +$522.3K |
| Cogent Biosciences, Inc.(COGT) | 5,566,026 | 5,566,026 | 0 | $54.27M | $32.73M | 2.86% | -$21.54M |
| Alpine Immune Sciences Inc | 1,325,000 | 1,610,000 | +285,000 | $15.17M | $30.69M | 2.68% | +$15.52M |
| Soleno Therapeutics Inc | 887,500 | 700,000 | -187,500 | $26.19M | $28.18M | 2.46% | +$1.98M |
| Celldex Therapeutics, Inc.(CLDX) | 706,665 | 701,967 | -4,698 | $19.45M | $27.84M | 2.43% | +$8.39M |
| Celcuity Inc.(CELC) | 1,694,141 | 1,754,704 | +60,563 | $15.48M | $25.57M | 2.23% | +$10.08M |
| Rayzebio Inc | 288,911 | 383,638 | +94,727 | $6.41M | $23.85M | 2.08% | +$17.44M |
| Pharvaris N V COM | 0 | 800,000 | +800,000 | $0 | $22.44M | 1.96% | +$22.44M |
| C4 Therapeutics, Inc.(CCCC) | 0 | 3,800,000 | +3,800,000 | $0 | $21.47M | 1.88% | +$21.47M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 1,895,003 | +1,895,003 | $0 | $20.28M | 1.77% | +$20.28M |
| Nkarta, Inc.(NKTX) | 0 | 2,730,000 | +2,730,000 | $0 | $18.02M | 1.57% | +$18.02M |
| Kura Oncology, Inc.(KURA) | 1,400,000 | 1,248,062 | -151,938 | $12.77M | $17.95M | 1.57% | +$5.18M |
| Harpoon Therapeutics Inc | 0 | 1,500,000 | +1,500,000 | $0 | $17.05M | 1.49% | +$17.05M |
| Akero Therapeutics Inc | 565,000 | 565,000 | 0 | $28.58M | $13.19M | 1.15% | -$15.38M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 900,000 | +900,000 | $0 | $11.97M | 1.05% | +$11.97M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $8.25M | $8.10M | 0.71% | -$157.5K |
| Third Harmonic Bio Inc | 1,700,000 | 706,706 | -993,294 | $10.86M | $7.75M | 0.68% | -$3.11M |
| Adverum Biotechnologies Inc | 10,000,000 | 10,000,000 | 0 | $15.00M | $7.53M | 0.66% | -$7.47M |
| Apogee Therapeutics Inc | 250,000 | 250,000 | 0 | $5.33M | $6.99M | 0.61% | +$1.66M |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 1,831,746 | +1,831,746 | $0 | $1.26M | 0.11% | +$1.26M |
| Dbv Technologies S AADR | 92,687 | 92,687 | 0 | $126.1K | $88.3K | 0.01% | -$37.7K |
| AMBRX BIOPHARMA INCSPONSORED ADS | 3,518,556 | 0 | -3,518,556 | $40.46M | $0 | — | -$40.46M |
| CRINETICS PHARMACEUTICALS INCOM(CRNX) | 500,000 | 0 | -500,000 | $14.87M | $0 | — | -$14.87M |
| DAY ONE BIOPHARMACEUTICALS ICOM COM | 739,661 | 0 | -739,661 | $9.08M | $0 | — | -$9.08M |
| IDEAYA BIOSCIENCES INCCOM(IDYA) | 775,000 | 0 | -775,000 | $20.91M | $0 | — | -$20.91M |
| MERSANA THERAPEUTICS INCCOM | 2,244,378 | 0 | -2,244,378 | $2.85M | $0 | — | -$2.85M |
| SYNDAX PHARMACEUTICALS INCCOM(SNDX) | 957,509 | 0 | -957,509 | $13.90M | $0 | — | -$13.90M |